Welcome

to Oslo Medtech

Register here to subscribe to our newsletter!


 

First Name:
Last Name:
Email Address:
Subscribe
Unsubscribe

Oslo Medtech News

Generating innovation. For better living and health.

News Archive
Sensometrics Technology convinces

Trond Stadheim, dPCom AS, is happy to announce good results of clinical trialsA clinical trial at the Oslo University Hospital – Rikshospitalet, indicates that patients with intracranial aneurysm bleeds treated with Sensometrics Technology, were more than three times as likely to recover completely as compared to patients treated with traditional methods. Based on the findings, the hospital will integrate Sensometrics as its new, standard treatment method.

dPCom AS, the producer of Sensometrics Technology, is pleased to announce that the results of the study, which are published in the November, 2011 issue of NEUROSURGERY, show that 1 in 3 in the Sensometrics group recovered completely, compared with1 in 10 in the group treated by traditional practices.

Physicians at Oslo University Hospital were impressed by the performance of Sensometrics. “The results of the study represent a breakthrough in our field and have the potential to change the industry standard for patient treatment,” states Dr. Wilhelm Sorteberg, Head of Vascular Neurosurgery, Department of Neurosurgery, Oslo University Hospital. Regarding the decision to integrate Sensometrics Technology as standard practice, he adds, “These results are convincing and cannot be ignored. It is our responsibility to offer our patients the best possible chance of a full recovery, and Sensometrics clearly enhances their prognoses".

Sensometrics Technology by dPCom AS



www.dpcom.com

 
Utviklet av React Solutions og designet av Rim Ide & kommunikasjon